Fuji Pharma Co.,Ltd.
4554・Prime Market・Pharmaceuticals
Fuji Pharma Co.,Ltd.4554
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-07-17 | Other | 役員人事に関するお知らせ |
| 2026-07-17 | Other | [Delayed] Notice of Publication of the Company Research and Analysis Report by FISCO Ltd. |
| 2026-07-17 | Other | 組織改編ならびに人事異動のお知らせ |
| 2026-06-25 | Other | 株式会社フィスコによる企業調査レポート公開のお知らせ |
| 2026-05-19 | Other | バイオ後続品（バイオシミラー）3製品の薬価基準収載のお知らせ |
| 2026-05-13 | Other | 半期報告書－第62期(2025/10/01－2026/09/30) |
| 2026-05-12 | Other | Notice Regarding Loss on Valuation of Securities for the Second Quarter of the Fiscal Year ending September 2026 |
| 2026-05-12 | Earnings Report | 2026年９月期第２四半期(中間期)決算短信〔日本基準〕(連結) |
| 2026-05-12 | Other | Consolidated Financial Results for the Six Months Ended March 31, 2026 [Japanese GAAP] |
| 2026-05-12 | Other | 2026年９月期第２四半期有価証券評価損に関するお知らせ |